152 related articles for article (PubMed ID: 36650727)
1. Orbital Manifestation of Immune Reconstitution Inflammatory Syndrome in Whipple's Disease.
Feurle GE; Moos V
Dtsch Arztebl Int; 2022 Oct; 119(43):734. PubMed ID: 36650727
[No Abstract] [Full Text] [Related]
2. [Whipple's disease].
Moos V; Schneider T
Dtsch Med Wochenschr; 2014 Dec; 139(49):2507-9. PubMed ID: 25423457
[No Abstract] [Full Text] [Related]
3. Erythematous skin nodules during treatment of Whipple's disease.
Sanchez A; Del Giudice P; Mantion C; Mazellier S; Boukari F; Roger PM; Courjon J
Infect Dis Now; 2021 Jun; 51(4):397-399. PubMed ID: 33075401
[No Abstract] [Full Text] [Related]
4. Granulomatous lung disease and immune reconstitution inflammatory syndrome in Whipple's disease.
Hofmann P; Durisch N; Buetikofer C; Helmchen BM
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34144955
[TBL] [Abstract][Full Text] [Related]
5. Erythema nodosum-like lesions in treated Whipple's disease: signs of immune reconstitution inflammatory syndrome.
Schaller J; Carlson JA
J Am Acad Dermatol; 2009 Feb; 60(2):277-88. PubMed ID: 19150271
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations in treated Whipple's disease.
van der Bent S; van Vugt M; Amir A; van der Wal A; Mekkes J
Int J Dermatol; 2017 Apr; 56(4):e82-e84. PubMed ID: 28181229
[No Abstract] [Full Text] [Related]
7. Immune reconstitution inflammatory syndrome during treatment of Whipple's disease.
Vayssade M; Tournadre A; D'Incan M; Soubrier M; Dubost JJ
Joint Bone Spine; 2015 Mar; 82(2):122-4. PubMed ID: 25553832
[TBL] [Abstract][Full Text] [Related]
8. "Immune reconstitution inflammatory syndrome"-a rare complication of Whipple's disease.
Kapoor S
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1045-6. PubMed ID: 27056554
[No Abstract] [Full Text] [Related]
9. Tropheryma whipplei infection and Whipple's disease.
Marth T; Moos V; Müller C; Biagi F; Schneider T
Lancet Infect Dis; 2016 Mar; 16(3):e13-22. PubMed ID: 26856775
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.
Lagier JC; Fenollar F; Lepidi H; Liozon E; Raoult D
J Infect; 2010 Jan; 60(1):79-82. PubMed ID: 19852981
[TBL] [Abstract][Full Text] [Related]
11. [Whipple's disease: progress in the diagnosis and review of the literature].
Ghittoni G; Valentini G; Spada C; De Vitis I; Rossi Z; Gasbarrini G
Minerva Med; 2002 Dec; 93(6):447-51. PubMed ID: 12515967
[TBL] [Abstract][Full Text] [Related]
12. Immunopathology of immune reconstitution inflammatory syndrome in Whipple's disease.
Moos V; Feurle GE; Schinnerling K; Geelhaar A; Friebel J; Allers K; Moter A; Kikhney J; Loddenkemper C; Kühl AA; Erben U; Fenollar F; Raoult D; Schneider T
J Immunol; 2013 Mar; 190(5):2354-61. PubMed ID: 23365082
[TBL] [Abstract][Full Text] [Related]
13. Previous immunosuppressive therapy is a risk factor for immune reconstitution inflammatory syndrome in Whipple's disease.
Biagi F; Trotta L; Di Stefano M; Balduzzi D; Marchese A; Vattiato C; Bianchi PI; Fenollar F; Corazza GR
Dig Liver Dis; 2012 Oct; 44(10):880-2. PubMed ID: 22704397
[TBL] [Abstract][Full Text] [Related]
14. [Whipple's disease and central nervous system].
Bermejo P; Burgos A
Med Clin (Barc); 2006 Sep; 127(10):379-85. PubMed ID: 16987484
[No Abstract] [Full Text] [Related]
15. Whipple's disease.
Puéchal X
Ann Rheum Dis; 2013 Jun; 72(6):797-803. PubMed ID: 23291386
[TBL] [Abstract][Full Text] [Related]
16. [Whipple's disease: neurologic manifestations and review of cases published in the Spanish literature].
Ojeda E; Redondo J; Lapaza J; Ruiz I; Alzate LF
Rev Clin Esp; 1988 Nov; 183(7):365-7. PubMed ID: 2463653
[No Abstract] [Full Text] [Related]
17. [The articular manifestations of Whipple's disease. Apropos of a case, with histological study of the synovial membrane].
Delcambre B; Luez J; Léonardelli J; Paris JC; Mairesse M; Robert d' Eshougues J
Sem Hop; 1974 Mar; 50(13):847-55. PubMed ID: 4137472
[No Abstract] [Full Text] [Related]
18. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study.
Feurle GE; Moos V; Schinnerling K; Geelhaar A; Allers K; Biagi F; Bläker H; Moter A; Loddenkemper C; Jansen A; Schneider T
Ann Intern Med; 2010 Dec; 153(11):710-7. PubMed ID: 21135294
[TBL] [Abstract][Full Text] [Related]
19. [Acute intracranial hypertension and anicteric cholestasis revealing Whipple's disease without digestive involvement].
Lévy S; Degott C; Redondo A; Benhamou JP; Bernuau J
Gastroenterol Clin Biol; 2001 Jan; 25(1):100-2. PubMed ID: 11275624
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations.
Mahnel R; Kalt A; Ring S; Stallmach A; Strober W; Marth T
Am J Gastroenterol; 2005 May; 100(5):1167-73. PubMed ID: 15842595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
